Qiming Venture Partners Wishes You a Happy Lantern Festival of Harmony, Fulfillment, and Good Fortune
A New Year Dawns; Spring's Tidings Have Arrived
The Lantern Festival on the 15th day of the first lunar month
A new year begins, spring's promise has arrived
Qiming Venture Partners wishes you harmony, fulfillment, and good health
Long-press to save the two posters below
Feel free to share!
Poster 1: Steed Welcoming Spring
Poster 2: Fortune's Grand Beginning
PAST HIGHLIGHTS
Qiming Honors | 5 Qiming Venture Partners Investors Named to ChinaVenture's 2025 Investor Rankings
Qiming Honors | 5 Qiming Venture Partners Investors Named to Forbes China's 2025 Midas List
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative enterprises, of which more than 210 have gone public on the NYSE, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many of Qiming Venture Partners' portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ:HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ:WRD, 00800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Biren Technology (06082.HK), Zhipu (02513.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), SinoCellTech (688520.SH), Insilico Medicine (03696.HK), Argo Biopharma, Yuanxin Technology, MediLink Therapeutics, LaNova Medicines, StepFun, and others.